ArticleClinical and experimental medicine2025

MiR-101-3p targets the PI3K-AKT signaling pathway via Birc5 to inhibit invasion, proliferation, and epithelial-mesenchymal transition in hepatocellular carcinoma.

Wenyuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.